Search
for
Sort by
Research 61–90 of 1000+
- Cutaneous Corticosteroid Injection and Amaurosis
- Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Comparative Outcomes of Cutaneous Vesicostomy Versus Cystoscopic Valve Ablation in the Initial Management of Posterior Urethral Valves
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Dermatologic adverse effect of subcutaneous furosemide administration in a cat
- Ketoconazole-p Aminobenzoic Cocrystal Exhibits a Potent Anti-inflammatory Effect on the Skin of BALBc Mice
- Interferon in the treatment of cutaneous T-cell lymphoma
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUES
- Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions
- Recent Advances in the Controlled Release of Growth Factors and Cytokines for Improving Cutaneous Wound Healing
- Cutaneous Atrophy and Alopecia After Greater Occipital Nerve Injection Using Triamcinolone
- Generalised cutaneous necrosis: a complication of low-molecular-weight heparin
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Dermatological adverse events with taxane chemotherapy
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Hypertrichosis induced by latanoprost
- Complications of Mesotherapy
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Mucocutaneous reactions to chemotherapy
- Docetaxel.
- Cutaneous manifestations of anabolic-androgenic steroid use in athletes
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- ANDROGENETIC ALOPECIA
- Recent advances in the treatment of psoriasis
- Alopecia areata after mogamulizumab treatment